Tenaya Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
TNYA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
171 Oyster Point Blvd., Suite 500, South San Francisco, California

Insiders trading volume in the past year

Tenaya Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David V. Goeddel Director, 10%+ Owner $61.2 M +$10 M +19.5% Feb 12, 2024
Column Group III Gp, Lp 10%+ Owner $61.2 M +$10 M +19.5% Feb 12, 2024
Eli Casdin Director $25.9 M Nov 17, 2022
Timothy Hoey Chief Scientific Officer $1.72 M -$132 K -7.12% Mar 5, 2024
Casdin Partners Master Fund, L.P. 10%+ Owner $1.54 M Aug 3, 2021
Faraz Ali Chief Executive Officer, Director $1.22 M -$58.5 K -4.57% Feb 23, 2024
Whittemore Tingley Chief Medical Officer $669 K -$59.3 K -8.14% Feb 23, 2024
Leone D. Patterson Chief Fin. and Bus. Officer $590 K -$47.4 K -7.44% Feb 23, 2024
JeenJoo Kang Director $107 K Aug 3, 2021
R. Sanders Williams Director Jun 9, 2023
Jin Long Chen Director Jun 9, 2023
Amy L. Burroughs Director Jun 9, 2023
Karah Parschauer Director Jun 9, 2023
Catherine Stehman-Breen Director Jun 9, 2023
June Lee Director Jun 9, 2023
Deepak Srivastava Director Jun 9, 2023
Jeffrey T. Walsh Director Jun 9, 2023

Recent Insider Transactions by Companies or Individuals for Tenaya Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership